Suppr超能文献

小鼠干细胞因子与多种细胞因子联合对短期悬浮培养中小鼠造血祖细胞扩增的协同作用。

Synergistic effects of murine stem cell factor in combination with a variety of cytokines on the expansion of murine hematopoietic progenitor cells in short-term suspension cultures.

作者信息

Han M

机构信息

Third Department of Internal Medicine, Hokkaido University School of Medicine, Sapporo, Japan.

出版信息

Hokkaido Igaku Zasshi. 1992 Sep;67(5):674-83.

PMID:1385289
Abstract

In the present study, it is represented that the ability of murine stem cell factor (SCF) to expand hematopoietic progenitor cells in short-term suspension culture when used alone or with IL-1 beta, IL-3, IL-6, M-CSF and IL1 beta Plus IL-3. SCF alone had a limited effect on the expansion of early primitive hematopoietic progenitor cells (CFU-HPP: high proliferative potential colony forming unit, and CFU-S: colony forming unit in spleen) even at a high concentration, but expanded mature hematopoietic progenitor cells (CFU-GM: colony forming unit-granulocyte/macrophage, and BFU-E: burst forming unit-erythroid) markedly at low concentrations. When SCF was used in combination with other cytokines, the expansion of primitive hematopoietic progenitor cells was significantly increased; namely, CFU-HPP were expanded approximately 2 to 5-fold compared with SCF alone. A marked expansion of hematopoietic progenitor cells was observed in a combination of SCF plus IL-1 beta plus IL-3. In this setting, CFU-S was increased 2.2-fold compared with the number of CFU-S in fresh bone marrow and CFU-HPP were increased 8.5-fold compared with the number of primary CFU-HPP. These results suggest that these factors may be utilized in experiments of murine bone marrow transplantation (BMT) and also in human BMT. Namely, the adequate number of hematopoiesic progenitor cells and stem cells required for the successful engraftment can be obtained from small volume of peripheral or bone marrow blood by this procedure, thus obtiating the donor's burden.

摘要

在本研究中,表明小鼠干细胞因子(SCF)单独使用或与白细胞介素-1β(IL-1β)、白细胞介素-3(IL-3)、白细胞介素-6(IL-6)、巨噬细胞集落刺激因子(M-CSF)以及IL-1β加IL-3一起使用时,在短期悬浮培养中扩增造血祖细胞的能力。单独的SCF即使在高浓度下对早期原始造血祖细胞(CFU-HPP:高增殖潜能集落形成单位,以及CFU-S:脾集落形成单位)的扩增作用有限,但在低浓度时能显著扩增成熟造血祖细胞(CFU-GM:粒细胞/巨噬细胞集落形成单位,以及BFU-E:红细胞爆式集落形成单位)。当SCF与其他细胞因子联合使用时,原始造血祖细胞的扩增显著增加;即,与单独使用SCF相比,CFU-HPP扩增了约2至5倍。在SCF加IL-1β加IL-3的组合中观察到造血祖细胞的显著扩增。在这种情况下,与新鲜骨髓中的CFU-S数量相比,CFU-S增加了2.2倍,与原始CFU-HPP数量相比,CFU-HPP增加了8.5倍。这些结果表明,这些因子可用于小鼠骨髓移植(BMT)实验以及人类BMT。也就是说,通过该程序可从小体积的外周血或骨髓血中获得成功植入所需的足够数量的造血祖细胞和干细胞,从而减轻供体的负担。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验